Dietary inflammatory index and dietary energy density are associated with menopausal symptoms in postmenopausal women: a cross-sectional study
- 14 February 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 27 (5) , 568-578
Abstract
Objectives: No previous study has evaluated the association of the dietary inflammatory index (DII) and dietary energy density (DED) with menopausal symptoms and its subclasses in postmenopausal women. The aim of this study was to evaluate the association of DII score and DED with menopausal symptoms and its subtypes in Iranian postmenopausal women. Methods: This cross-sectional study was conducted on 393 postmenopausal women who attended health centers in the south of Tehran, Iran. The DII score was calculated using dietary factors obtained by a validated food frequency questionnaire. DED was defined as average daily energy intake (kcal) per gram of food. The Menopause Rating Scale questionnaire was used to evaluate the menopausal symptoms. The total Menopause Rating Scale score (TMRSS) was the sum of the somatic score (SS), psychological score (PS), and urogenital score. Linear regression analysis was used to assess the association of the DII score and DED with menopausal symptoms. Results: After adjusting for covariates, participants in the highest tertile of DII score had greater SS compared to those in the lowest tertile (βDIIt3vs1= 0.032, 95% confidence interval (CI): 0.004-0.068, P = 0.04). No significant relationship was found between DII score and PS, urogenital score or TMRSS. Furthermore, higher DED was associated with greater SS (βDIIt3vs1 = 0.071, 95% CI: 0.028-0.115, P = 0.001), PS (βDIIt3vs1 = 0.065, 95% CI: 0.012-0.121, P = 0.01) and TMRSS (βDIIt3vs1 = 0.053, 95% CI: 0.017-0.088, P = 0.004). Conclusion: A proinflammatory diet was associated with higher menopause-specific somatic symptoms and higher DED was positively associated with menopausal symptoms.Keywords
This publication has 55 references indexed in Scilit:
- Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysisDiabetologia, 2009
- A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomniaSleep Medicine, 2009
- Complementary and Alternative Medicine Use for Vasomotor Symptoms Among Women Who Have Discontinued Hormone TherapyJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2009
- Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal WomenAmerican Journal of Epidemiology, 2008
- Dietary factors and vasomotor symptoms in breast cancer survivorsMenopause, 2006
- Lifestyle and Demographic Factors in Relation to Vasomotor Symptoms: Baseline Results from the Study of Women's Health Across the NationAmerican Journal of Epidemiology, 2004
- Adipose Tissue as an Endocrine OrganThe Journal of Clinical Endocrinology & Metabolism, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Changes in Proinflammatory Cytokine Activity after MenopauseEndocrine Reviews, 2002
- Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001Menopause, 2001